Incannex Healthcare News - IXHL

Company Name	Stock Ticker Symbol	Market	Type
Incannex Healthcare Ltd	IXHL	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	2.38	19:53:42

Open Price	Low Price	High Price	Close Price	Prev Close
2.40	2.35	2.44	2.38	2.38

more quote information »

Recent News

Date	Time	Source	Heading
4/16/2024	08:00	GLOBE	Incannex Healthcare Inc. Quarterly Update, Q1 2024
2/28/2024	07:30	GLOBE	Incannex Announces Positive Topline Results from Phase 2..
2/16/2024	08:00	EDGAR2	Form 8-K - Current report
2/16/2024	07:30	GLOBE	Incannex Completes Successful Pre-IND Meeting with the FDA..
2/14/2024	06:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/01/2024	07:30	EDGAR2	Form 8-K - Current report
2/01/2024	07:30	GLOBE	Clarion Clinics Open for Psychedelic-Assisted Treatments
1/24/2024	16:30	EDGAR2	Form 8-K - Current report
1/24/2024	16:05	GLOBE	Incannex Commences Dosing in Phase 2 Clinical Trial..
1/18/2024	09:08	EDGAR2	Form 8-K - Current report
1/18/2024	08:22	GLOBE	Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD”..
1/17/2024	07:30	GLOBE	Incannex Receives IRB Approval for the RePOSA Phase 2/3..
1/17/2024	06:05	EDGAR2	Form 8-K - Current report
12/22/2023	06:07	EDGAR2	Form 8-K - Current report
12/21/2023	20:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/21/2023	20:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/21/2023	20:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/21/2023	20:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/21/2023	16:05	GLOBE	Clarion Clinics Receives Ethics Board Endorsement for the..
12/20/2023	17:05	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
12/06/2023	07:30	GLOBE	Incannex Update on IHL-42X Drug Candidate in Phase 2/3..
11/29/2023	13:40	GLOBE	Incannex Healthcare Announces Completion of..
11/16/2023	09:38	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/16/2023	08:30	GLOBE	Federal Court of Australia Approves Incannex’s..
11/08/2023	06:07	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/26/2023	06:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/08/2023	07:30	GLOBE	Incannex Announces Participation at the H.C. Wainwright 25th..
9/08/2023	06:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/01/2023	08:43	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/24/2023	07:30	GLOBE	Incannex to Prepare FDA IND Application for..
8/22/2023	07:30	GLOBE	Review of IND Application for IHL-42X by US FDA has been..
8/08/2023	08:00	GLOBE	Clarion Clinics Begins Accepting Registrations for..
8/08/2023	06:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/28/2023	07:30	GLOBE	Incannex Healthcare June 2023 Quarterly Activities Report..
7/26/2023	07:30	GLOBE	Incannex Completes Positive Pre-IND Meeting with US FDA on..
7/21/2023	09:09	GLOBE	Incannex Submits IND Application to the US FDA for IHL-42X..
7/18/2023	07:40	GLOBE	Incannex engages Fortrea to Manage its FDA IND Opening Phase..
7/13/2023	08:00	GLOBE	Incannex Receives HREC Approval for Phase 2 Clinical Trial..
7/13/2023	06:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/10/2023	08:43	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/10/2023	07:30	GLOBE	Incannex Announces Intention to Redomicile to United States,..
7/06/2023	08:42	GLOBE	Incannex Receives Ethics Approval for..
6/23/2023	08:00	GLOBE	Incannex Announces Participation at the H.C. Wainwright 4th..
6/16/2023	08:00	GLOBE	Incannex Appoints Principal Investigators for IHL-42X Phase..
5/30/2023	08:00	GLOBE	World Renowned International Psychedelics Experts Join..
5/16/2023	07:50	GLOBE	Incannex Company Presentation – Presentation of Psychennex,..
5/05/2023	07:30	GLOBE	Incannex enters a lease for first psychedelic-assisted..
5/03/2023	07:30	GLOBE	Incannex Company Presentation – Results from Phase 1..
5/02/2023	07:30	GLOBE	Incannex Announces Final Results from Phase 1 Clinical Trial..